Therefore, TNF inhibitory approaches successfully entered the clinic for therapy of e.g. rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD) [1]. The gene discussed is TNF; the disease is rheumatoid arthritis.